Hereditary Transthyretin Amyloidosis With Polyneuropthy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hereditary Transthyretin Amyloidosis With Polyneuropthy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04850105

A Non-interventional Cohort Safety Study of Patients With hATTR-PN

This is a prospective, non-interventional, Long-term, multinational cohort safety study of patients with Hereditary Transthyretin Amyloidosis with Polyneuropath…

Bulgaria, Cyprus, France240 participantsStarted 2021-09-21

Treatment: Data Collection

All recent trials (2 shown)

TerminatedPhase 4

NCT04306510

A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hAT…

The objective of the study was to characterize adverse events (AEs) occurring within one day of TEGSEDI administration to adult participants with hATTR-PN overa…

United States, Canada8 participantsStarted 2021-01-21

Treatment: TEGSEDI